As far as we know, this is the first study to report elevated CRM1 expression as an independent prognostic marker for poor clinical course and overall survival in laryngeal cancer patients diagnosed with squamous cell carcinoma. This evidence concerns the gene XPO1 and squamous cell carcinoma.